Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation

被引:46
|
作者
Chang, H
Qi, XY
Samiee, S
Yi, QL
Chen, C
Trudel, S
Mikhael, J
Reece, D
Stewart, AK
机构
[1] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Lab Hematol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
基金
加拿大健康研究院;
关键词
multiple myeloma; IgH translocations; 13q deletions; p53; deletions; fluorescence in situ hybridization; autologous stem cell transplantation;
D O I
10.1038/sj.bmt.1705131
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Genetic aberrations have emerged as major prognostic factors for patients with multiple myeloma ( MM). We evaluated 126 MM patients for t(4; 14) or t(11; 14), 13q or p53 deletions and correlated the number of genetic aberrations with patient's clinical outcome following undergoing autologous stem cell transplantation. W e demonstrate the significance of genetic-based risk classification that clearly segregate patients into low ( no genetic abnormalities or only t( 11; 14)), intermediate ( any one of the genetic abnormalities other than t( 11; 14)) and high-risk groups ( any two or more of the genetic abnormalities other than t( 11; 14)). High-risk patients do not bene. t from stem cell transplant and should be offered alternative therapies.
引用
收藏
页码:793 / 796
页数:4
相关论文
共 50 条
  • [1] Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation
    H Chang
    X Y Qi
    S Samiee
    Q-L Yi
    C Chen
    S Trudel
    J Mikhael
    D Reece
    A K Stewart
    Bone Marrow Transplantation, 2005, 36 : 793 - 796
  • [2] Toxicity and Benefit of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma
    Maia, Tania
    Marini, Carolina
    Medeiros, Pedro
    Bergantim, Rui
    Aguiar, Eliana Vale
    Pires, Jorge Cancela
    Trigo, Fernanda
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E134 - E135
  • [3] Do Patients With Multiple Myeloma Still Need Autologous Stem Cell Transplantation?
    Patel, Krina
    ONCOLOGY-NEW YORK, 2023, 37 (07): : 309 - 313
  • [4] Autologous stem cell transplantation for patients with multiple myeloma
    Demirer, T
    Bensinger, WI
    Appelbaum, FR
    Rowley, SD
    Buckner, CD
    BLOOD, 1995, 86 (10) : 815 - 815
  • [5] Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation
    Sharma, Atul
    Lokeshwar, Nilesh
    Raina, Vinod
    Mohanti, Bidhu K.
    Kumar, Rajive
    NATIONAL MEDICAL JOURNAL OF INDIA, 2007, 20 (03): : 121 - 124
  • [6] AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY MULTIPLE MYELOMA PATIENTS
    Staderini, M.
    Nozzoli, C.
    Antonioli, E.
    Donnini, I.
    Cutini, I.
    Guarrera, A. S.
    Di Gioia, M.
    Gozzini, A.
    Guidi, S.
    Bosi, A.
    Saccardi, R.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [7] Autologous stem cell transplantation for multiple myeloma in elderly patients
    Eibl, M
    Zinke-Cerwenka, W
    Neumeister, P
    Wölfler, A
    Sill, H
    Linkesch, W
    BONE MARROW TRANSPLANTATION, 2004, 33 : S357 - S357
  • [8] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Patir, P.
    Soyer, N.
    Tombuloglu, M.
    Tobu, M.
    Sahin, F.
    Donmez, A.
    Saydam, G.
    Vural, F.
    LEUKEMIA RESEARCH, 2016, 49 : S27 - S28
  • [9] Autologous Stem Cell Transplantation in Elderly Multiple Myeloma Patients
    Staderini, Michela
    Antonioli, Elisabetta
    Nozzoli, Chiara
    Donnini, Irene
    Cutini, Ilaria
    Guidi, Stefano
    Gozzini, Antonella
    Bosi, Alberto
    Guarrera, Agata
    Saccardi, Riccardo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E85 - E86
  • [10] AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY MULTIPLE MYELOMA PATIENTS
    Staderini, M.
    Nozzoli, C.
    Antonioli, E.
    Donnini, I.
    Cutini, I.
    Guarrera, A. S.
    Di Gioia, M.
    Gozzini, A.
    Guidi, S.
    Bosi, A.
    Saccardi, R.
    HAEMATOLOGICA, 2017, 102 : 789 - 790